BAT progresses COVID-19 candidate vaccine into Phase-I human clinical trials

Islamabad : British American Tobacco’s US Bio-tech arm, Kentucky BioProcessing  (KBP) today announced plans to commence a Phase I first-time-in-human study of its COVID-19 vaccine candidate following approval of its Investigational…